Sen. Alexander Issues Statement at Committee Hearing on Drug Pricing
May 15, 2018
May 15, 2018
WASHINGTON, May 15 -- The office of Sen. Lamar Alexander, R-Tennessee, chairman of the Senate Health, Education, Labor and Pensions Committee, issued the following floor statement at a committee hearing entitled "Examining Oversight Reports on the 340B Drug Pricing Program":
"The Senate Committee on Health, Education, Labor and Pensions will please come to order.
"Last Friday, President Trump and Secretary Azar announced a blue print on drug pricing . . .
"The Senate Committee on Health, Education, Labor and Pensions will please come to order.
"Last Friday, President Trump and Secretary Azar announced a blue print on drug pricing . . .